
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Dec 24, 2025 05:24 am UTC| Governance Business Health
Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving mitapivat for the treatment of anemia in adults with alpha- or beta-thalassemia. The approval represents...

Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Dec 24, 2025 03:42 am UTC| Business Health
Global pharmaceutical leaders Eli Lilly and Novo Nordisk are intensifying competition in Indias rapidly expanding obesity drug market as they race to secure dominance before lower-cost generic alternatives arrive in early...

Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Dec 23, 2025 01:57 am UTC| Business Health
Novo Nordisk A/S (NYSE: NVO) shares jumped nearly 8% in after-hours trading on Monday following a major regulatory milestone: the U.S. Food and Drug Administration approved the companys Wegovy pill, making it the first...

AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dec 22, 2025 07:39 am UTC| Business Health
AstraZeneca PLC (NASDAQ: AZN) announced on Monday that its Phase III LATIFY clinical trial evaluating ceralasertib in non-small cell lung cancer (NSCLC) did not achieve its primary endpoint. The late-stage study assessed...

FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Dec 20, 2025 01:55 am UTC| Governance Health Business
The U.S. Food and Drug Administration (FDA) has authorized the marketing of six on! PLUS nicotine pouch products owned by Altria Group, marking the first approvals granted under the agencys new pilot program designed to...

Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Dec 17, 2025 07:02 am UTC| Business Health
Sanofi (EURONEXT: SAN) announced Wednesday that its investigational therapy, efdoralprin alfa, has received orphan drug designation from the European Medicines Agency (EMA) for the treatment of alpha-1 antitrypsin...

FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Dec 16, 2025 04:35 am UTC| Governance Health Business
The U.S. Food and Drug Administration (FDA) has no plans to place a black box warningthe most serious safety labelon COVID-19 vaccines, according to a recent Bloomberg News report citing FDA Commissioner Marty Makary. The...